Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

The recruitment status of this study is unknown because the information has not been verified recently.
Verified March 2011 by Bispebjerg Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Bispebjerg Hospital
ClinicalTrials.gov Identifier:
NCT01349361
First received: May 5, 2011
Last updated: NA
Last verified: March 2011
History: No changes posted

May 5, 2011
May 5, 2011
March 2011
January 2013   (final data collection date for primary outcome measure)
complete disappearance of the BCC
Same as current
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight

Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.

Not Provided
Interventional
Phase 2
Not Provided
  • Photodynamic Therapy
  • Basal Cell Carcinomas
Procedure: Daylight mediated photodynamic therapy
Experimental: Daylight-PDT
Intervention: Procedure: Daylight mediated photodynamic therapy
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
Not Provided
Not Provided
January 2013   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • superficial BCC

Exclusion Criteria:

  • Immunosuppression
Both
18 Years and older
Not Provided
Contact: Stine R Wiegell, MD, PhD swie0001@bbh.regionh.dk
Denmark
 
NCT01349361
2010-024517-31
Not Provided
Hans Christian Wulf, Bispebjerg Hospital
Bispebjerg Hospital
Not Provided
Not Provided
Bispebjerg Hospital
March 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP